Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?

References

• Ashburn MA, Staats PS. Management of chronic pain. Lancet 1999;353:1865-9
   PubMed Web of Science ®Google Scholar
• Gureje O, Von KM, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in primary care. JAMA 1998;280:147-51
   PubMed Web of Science ®Google Scholar
• Becker N, Bondegaard TA, Olsen AK, et al. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 1997;73:393-400
   PubMed Web of Science ®Google Scholar
• Carrington RM, Engles-Horton LL, Weber MB, et al. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002;17:173-9
   PubMed Web of Science ®Google Scholar
• Management of chronic pain syndromes: issues and interventions. Pain Med 2005;6(Suppl 1):S1-S20
   Google Scholar
• Nicholson B, Ross E, Weil A, et al. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules. Curr Med Res Opin 2006;22:539-50
   PubMed Web of Science ®Google Scholar
• Morley-Forster PK, Clark AJ, Speechley M, Moulin DE. Attitudes toward opioid use for chronic pain: a Canadian physician survey. Pain Res Manag 2003;8:189-94
   PubMedGoogle Scholar
• Stannard C, Johnson M. Chronic pain management – can we do better? An interview-based survey in primary care. Curr Med Res Opin 2003;19:703-6
   PubMed Web of Science ®Google Scholar
• Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000;283:1710-14
   PubMed Web of Science ®Google Scholar
• Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996;11:203-17
   PubMed Web of Science ®Google Scholar
• Galvez R. Variable use of opioid pharmacotherapy for chronic noncancer pain in Europe: causes and consequences. J Pain Palliat Care Pharmacother 2009;23:346-56
   PubMedGoogle Scholar
• Katz WA. Use of nonopioid analgesics and adjunctive agents in the management of pain in rheumatic diseases. Curr Opin Rheumatol 2002;14:63-71
   PubMed Web of Science ®Google Scholar
• Davis MP, Srivastava M. Demographics, assessment and management of pain in the elderly. Drugs Aging 2003;20:23-57
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Manchikanti KN, Pampati V, Cash KA. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Pain Physician 2009;12:259-67
   PubMed Web of Science ®Google Scholar
• Cherny NI. Opioid analgesics: comparative features and prescribing guidelines. Drugs 1996;51:713-37
   PubMed Web of Science ®Google Scholar
• Bannwarth B. Risk-benefit assessment of opioids in chronic noncancer pain. Drug Saf 1999;21:283-96
   PubMed Web of Science ®Google Scholar
• Goodwin JL, Kraemer JJ, Bajwa ZH. The use of opioids in the treatment of osteoarthritis: when, why, and how?. Curr Pain Headache Rep 2005;9:390-8
   PubMedGoogle Scholar
• Chevlen E. Opioids: a review. Curr Pain Headache Rep 2003;7:15-23
   PubMedGoogle Scholar
• Christo PJ. Opioid effectiveness and side effects in chronic pain. Anesthesiol Clin North America 2003;21:699-713
   PubMedGoogle Scholar
• Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007;61:1181-7
   PubMed Web of Science ®Google Scholar
• Bell TJ, Panchal SJ, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med 2009;10:35-42
   PubMed Web of Science ®Google Scholar
• Dews TE, Mekhail N. Safe use of opioids in chronic noncancer pain. Cleve Clin J Med 2004;71:897-904
   PubMed Web of Science ®Google Scholar
• Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg 2007;105:205-21
   PubMed Web of Science ®Google Scholar
• Fitzcharles MA, DaCosta D, Ware MA, Shir Y. Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis. J Pain 2009;10:300-5
   PubMed Web of Science ®Google Scholar
• Hale M, Upmalis D, Okamoto A, et al. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study. Curr Med Res Opin 2009;25:1095-104
   PubMed Web of Science ®Google Scholar
• Daniels S, Casson E, Stegmann JU, et al. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr Med Res Opin 2009;25:1551-61
   PubMed Web of Science ®Google Scholar
• Daniels SE, Upmalis D, Okamoto A, et al. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Curr Med Res Opin 2009;25:765-76
   PubMed Web of Science ®Google Scholar
• Hartrick C, Van Hove I, Stegmann J-U, et al. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study. Clin Ther 2009;31:260-71
   PubMed Web of Science ®Google Scholar
• Cascorbi I. Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication. Eur J Clin Invest 2003;33(Suppl 2):17-22
   PubMed Web of Science ®Google Scholar
• Tzschentke TM, Christoph T, Kögel B, et al. (-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel μ opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther 2007;323:265-76
   PubMed Web of Science ®Google Scholar
• Tzschentke TM, De Vry J, Terlinden R, et al. Tapentadol HCl. Drugs Future 2006;31:1053-61
   Web of Science ®Google Scholar
• Terlinden R, Ossig J, Fliegert F, et al. Absorption, metabolism, and excretion of 14C-labeled tapentadol HCl in healthy male subjects. Eur J Drug Metab Pharmacokinet 2007;32:163-9
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov search of: tapentadol [online]. Available at: http://www.clinicaltrials.gov/ct2/results?term=tapentadol [Last accessed 22 Feb 2010]
   Google Scholar
• Sloan P, Babul N. Extended-release opioids for the management of chronic non-malignant pain. Expert Opin Drug Deliv 2006;3:489-97
   PubMedGoogle Scholar
• Rauck RL. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review. Pain Pract 2009;9:468-79
   PubMed Web of Science ®Google Scholar
• Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63:17-32
   PubMed Web of Science ®Google Scholar
• Kahan M, Srivastava A, Wilson L, et al. Opioids for managing chronic non-malignant pain: safe and effective prescribing. Can Fam Physician 2006;52:1091-6
   PubMed Web of Science ®Google Scholar
• Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunko E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174:1589-94
   PubMed Web of Science ®Google Scholar
• Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003;349:1943-53
   PubMed Web of Science ®Google Scholar
• Coluzzi F, Pappagallo M. Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy. Minerva Anestesiol 2005;71:425-33
   PubMedGoogle Scholar
• Nicholson B, Passik SD. Management of chronic noncancer pain in the primary care setting. South Med J 2007;100:1028-36
   PubMed Web of Science ®Google Scholar
• Sng BL, Schug SA. The role of opioids in managing chronic non-cancer pain. Ann Acad Med Singapore 2009;38:960-6
   PubMed Web of Science ®Google Scholar
• Trescot AM, Boswell MV, Atluri SL, et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006;9:1-39
   PubMedGoogle Scholar
• Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008;11:S5-S62
   PubMed Web of Science ®Google Scholar
• Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008;11:S105-20
   PubMed Web of Science ®Google Scholar
• Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 2005;293:3043-52
   PubMed Web of Science ®Google Scholar
• Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-80
   PubMed Web of Science ®Google Scholar
• Herndon CM, Jackson KC II, Hallin PA. Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy 2002;22:240-50
   PubMed Web of Science ®Google Scholar
• Thorpe DM. Management of opioid-induced constipation. Curr Pain Headache Rep 2001;5:237-40
   PubMedGoogle Scholar
• Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010;22:424--30
   Google Scholar
• Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001;182:11-18S
   PubMed Web of Science ®Google Scholar
• Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007;15:957-65
   PubMed Web of Science ®Google Scholar
• Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005;7:R1046-51
   PubMed Web of Science ®Google Scholar
• Bhamb B, Brown D, Hariharan J, et al. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006;22:1859-65
   PubMed Web of Science ®Google Scholar
• McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4:231-56
   PubMed Web of Science ®Google Scholar
• Nadstawek J, Leyendecker P, Hopp M, et al. Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain. Int J Clin Pract 2008;62:1159-67
   PubMed Web of Science ®Google Scholar
• Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008;358:2332-43
   PubMed Web of Science ®Google Scholar
• Meissner W, Leyendecker P, Mueller-Lissner S, et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 2009;13:56-64
   PubMed Web of Science ®Google Scholar
• Webster L, Jansen JP, Peppin J, et al. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain. Pain 2008;137:428-40
   PubMed Web of Science ®Google Scholar
• Johanson JF. Review of the treatment options for chronic constipation. MedGenMed 2007;9:25
   PubMedGoogle Scholar
• Roy S, Liu HC, Loh HH. mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit. Brain Res Mol Brain Res 1998;56:281-3
   PubMedGoogle Scholar
• Daniels SE, Upmalis D, Okamoto A, et al. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Curr Med Res Opin 2009;25:765-76
   PubMed Web of Science ®Google Scholar
• Rauschkolb-Loeffler C, Okamoto A, Steup A, Lange C. Efficacy and tolerability of tapentadol for relief of moderate-to-severe chronic pain due to osteoarthritis of the knee [abstract]. Ann Rheum Dis 2007;66(Suppl II):507
   Google Scholar
• Panchal SJ, Damaraju CV, Nelson WW, et al. System-related events and analgesic gaps during postoperative pain management with the fentanyl iontophoretic transdermal system and morphine intravenous patient-controlled analgesia. Anesth Analg 2007;105:1437-41
   PubMed Web of Science ®Google Scholar
• Buynak R, Shapiro D, Okamoto A, et al. Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain [abstract]. J Pain 2009;10:S48
   Google Scholar
• Kelly K, Kuperwasser B, Okamoto A, et al. Efficacy and gastrointestinal tolerability of tapentadol extended release in a randomized, double-blind, placebo- and active-controlled study in patients with moderate-to-severe chronic osteoarthritis knee pain [abstract]. Pain Pract 2009;9:161-2
   Google Scholar
• McQuay H. Opioids in pain management. Lancet 1999;353:2229-32
   PubMed Web of Science ®Google Scholar
• Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am 2007;91:199-211
   PubMed Web of Science ®Google Scholar
• Vardanya A, Wang R, Vanderah TW, et al. TRPV1 receptor in expression of opioid-induced hyperalgesia. J Pain 2009;10:243-52
   PubMed Web of Science ®Google Scholar
• Silverman SM. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician 2009;12:679-84
   PubMed Web of Science ®Google Scholar
• Collett BJ. Chronic opioid therapy for non-cancer pain. Br J Anaesth 2001;87:133-43
   PubMed Web of Science ®Google Scholar
• Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007;129:235-55
   PubMed Web of Science ®Google Scholar
• Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51
   PubMed Web of Science ®Google Scholar
• Fishbain DA, Cole B, Lewis J, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008;9:444-59
   PubMed Web of Science ®Google Scholar
• Haddox JD, Joranson D, Angarola RT, et al. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997;13:6-8
   PubMed Web of Science ®Google Scholar
• Pappagallo M, Heinberg LJ. Ethical issues in the management of chronic nonmalignant pain. Semin Neurol 1997;17:203-11
   PubMed Web of Science ®Google Scholar
• Kahan M, Srivastava A, Wilson L, et al. Misuse of and dependence on opioids: study of chronic pain patients. Can Fam Physician 2006;52:1081-7
   PubMed Web of Science ®Google Scholar
• Savage SR. Management of opioid medications in patients with chronic pain and risk of substance misuse. Curr Psychiatry Rep 2009;11:377-84
   PubMed Web of Science ®Google Scholar
• Auret K, Schug SA. Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem. Drugs Aging 2005;22:641-54
   PubMed Web of Science ®Google Scholar
• Blake S, Ruel B, Seamark C, Seamark D. Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: a patient-initiated study. Br J Gen Pract 2007;57:101-8
   PubMed Web of Science ®Google Scholar
• Barkin RL, Barkin SJ, Barkin DS. Perception, assessment, treatment, and management of pain in the elderly. Clin Geriatr Med 2005;21:465-90, v
   PubMed Web of Science ®Google Scholar
• Adriaensen H, Vissers K, Noorduin H, Meent T. Opioid tolerance and dependence: an inevitable consequence of chronic treatment?. Acta Anaesthesiol Belg 2003;54:37-47
   PubMedGoogle Scholar
• Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs 2003;35:253-9
   PubMed Web of Science ®Google Scholar
• Handelsman L, Cochrane KJ, Aronson MJ, et al. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987;13:293-308
   PubMed Web of Science ®Google Scholar
• Kleinert R, Lange C, Steup A, et al. Single dose analgesic efficacy of tapentadol in postsurgical dental pain: the results of a randomized, double-blind, placebo-controlled study. Anesth Analg 2008;107:2048-55
   PubMed Web of Science ®Google Scholar
• Stegmann J-U, Weber H, Steup A, et al. The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery. Curr Med Res Opin 2008;24:3185-96
   PubMed Web of Science ®Google Scholar